Icecure Medical H1 EPS $(0.17) Up From $(0.24) YoY, Sales $1.65M Up From $1.51M YoY
Portfolio Pulse from Benzinga Newsdesk
Icecure Medical (NASDAQ:ICCM) reported a 30% decrease in quarterly losses, from $(0.24) per share last year to $(0.17) per share this year. The company also reported a 8.93% increase in sales, from $1.51 million last year to $1.65 million this year.
August 14, 2023 | 12:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Icecure Medical reported a decrease in losses and an increase in sales, indicating a positive financial performance.
The decrease in losses and increase in sales reported by Icecure Medical indicates a positive financial performance. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100